The future of treatment for respiratory infection with kampo medicine-Reference-Cited by-同舟云学术

The future of treatment for respiratory infection with kampo medicine

Published:2021-09-01 Issue:5 Volume:28 Page:429-435
ISSN:1340-7988
Container-title:Journal of the Japanese Society of Intensive Care Medicine
language:en
Short-container-title:Nihon Shuchu Chiryo Igakukai zasshi

Author:

Ono Rie¹,Takayama Shin²,Arita Ryutaro¹

Affiliation:

1. Department of Education and Support for Regional Medicine, Tohoku University Hospital

2. Department of Kampo Medicine, Tohoku University Hospital

Publisher

Japanese Society of Intensive Care Medicine

Link

https://www.jstage.jst.go.jp/article/jsicm/28/5/28_28_429/_pdf

Reference38 articles.

1. 1) 小野理恵，髙山　真，有田龍太郎．呼吸器ウイルス感染症に対する東洋医学併用療法の集中治療における可能性．日集中医誌 2020;27:291-2.

2. 2) 安井廣迪. 日本漢方諸学派の流れ. 日東洋医誌 2007;58:177-202.

3. 3) 有田龍太郎，髙山　真，石沢興太，他．中国におけるCOVID-19に対する清肺排毒湯の報告．日本感染症学会． Available from: https://www.kansensho.or.jp/uploads/files/news/gakkai/covid19_kiko_0421.pdf（2020年11月29 日閲覧）

4. 4) Arita R, Ono R, Saito N, et al. Kakkonto, shosaikoto, Platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID‐19. Tradit Kampo Med 2020 Aug [cited 2020 Nov 30] Available from: http://doi.org/10.1002/tkm2.1258

5. 5) Shirayama R, Shoji M, Sriwilaijaroen N, et al. Inhibition of PA endonuclease activity of influenza virus RNA polymerase by Kampo medicines. Drug Discov Ther 2016;10:109-13.